Глава 3. Универсальные патогенетические механизмы развития хп • 161

82. C hen С. С, Wang S. S., Lu R. H. et al. Serum interleukin 10 and interleukin 11 in patients with acute pancreatitis // Gut.- 1999.-Vol. 45 (6).- P.895-899.

83. Chiari H bbewr selbstverdauung des menschlichen pancreas // Z. Heilkunde,— 1896.— Bd.l7.-S.69-95.

84. Comfort M. IV., Gaubill E. E., Baggenstos A. M. Chronic relapsing pancreatitis: a study of 29 cases without associated disease of the biliary or gastro-intestinal tract // Gastroenterol- ogy.— 1946.—Vol.6.— P. 239.

85. CookJ. W., Karakozis S., Kim D. et al. IL-10 attenuates promflammatory cytokine produc­ tion and improves survival in lethal pancreatitis // Am. Surg.—2001.—Vol. 67 (3).— P.237-241.

86. Coskun Т., Bozoklu S., Ozenc A., Ozdemir A. Effect of hydrogen peroxide on permeability of the main pancreatic duct and morphology of the pancreas // Amer. J. Surg.— 1998.— Vol. 176 (1).—P.53—58.

87. Dagorn J. С Lithostathine.— In: Go V. L. W., DiMagno E. P., Gardner J. D., Lebenthal E., Reber H. A., Scheele G. A. eds. The Pancreas: Biology, Pathobiology, and Disease.— 2nd ed.— New-York: Raven Press, Ltd, 1993.— P.253-263.

88. De Cam A., Lohse J., Sarles H. Characterization of a protein isolated from pancreatic cal­ culi of men suffering from chronic calcifying pancreatitis // Biochem. Biophys. Res. Com- mun,- 1979.— Vol.87.— P.I 176—1182.

89. De Reggi M., Capon C, Gharib B. et al. The glycan moiety of human pancreatic lithostath­ ine. Structure characterization and possible pathophysiological implications // Eur. J. Bio­ chem.— 1995.—Vol.230.- P.503—510.

90. De Reggi M., Gharib В., Patard L., Sloven V. Lithostathine, the presumed pancreatic stone inhibitor, does not interact specifically with calcium carbonate crystals // J. Biol. Chem.—

1998.- Vol.273.- P.4967-4971.

91. Demols A., Le Moine O., Desalle F. et al. CD4(+)T cells play an important role in acute ex­ perimental pancreatitis in mice // Gastroenterol.—2000.—Vol.118.— P.582—590.

92. Demols A., Deviere J. New frontiers in the pharmacological prevention of post-ERCP pancreatitis: The Cytokines // JOP. J. Pancreas (Online).— 2003.—Vol. 4 (1).— P 49— 57.

93. Denham W., Yang J., Fink G. et al. TNF but not IL-1 decreases pancreatic acinar cell sur­ vival without affecting exocrine function: a study in the perfused human pancreas // J. Surg. Res.— 1998.—Vol. 74 (1).—P.3-7.

94. Denham W., Norman J. The proteinal role of therapeutic cytokine manipulation in acute pancreatitis // Surg. Clin. North. Am.— 1999.—Vol. 79 (4).— P.767—781.

95. Deviere J., Le Moine O., Van Laethem J. L. et al. IL-10 reduces the incidence of pancrea­ titis after therapeutic endoscopic retrograde cholangiopancreatography // Gastroenterol.— 2001.-Vol. 120 (2).-P.498-505.

96. Di Mola F. F., Friess H., Martignoni M. E. et al. Connective tissue growth factor is a regu­ lator for fibrosis in human chronic pancreatitis // Ann. Surg.—1999.—Vol. 230 (1).— P.63-71.

97. Di Sebastiano P., di Mola F. F., Di Febbo F. F. et al. Expression of IL-8 and substance P in human chronic pancreatitis // Gut.— 2000.— Vol. 47 (3).— P.432—428.

98. DiMagno E. P., Go V. L. M., Summerskill W. H. J. Relation as between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency // N. Engl. J. Med.— 1973.— Vol. 288.-P.813-815.

99. DiMagno E. P., Malagalada J. R., Go V. L. M. Fate of orally ingested enzymes in pancre­ atic insufficiency // Comparison of two dosage schedules // N. Engl. J. Med.— 1977.— Vol. 296.—P.1318—1322.

100. Drickamer K, Taylor M. E. Biology of animal lectins // Annu. Rev. Cell. Biol.— 1993.— Vol.9.— P.237—264.

101. Dugernier Т., Laterre P. F., Reynaert M. S. Ascites fluid in severe acute pancreatiis: from pathophysiology to therapy // Acta. Gastroenterol. Belg.—2000.—Vol. 63 (3).—P.264— 268.

102. Dumot J. A., Conwell D. L., Zuccaro G. Jr. et al. A randomized, double blind study of IL- 10 for the prevention of ERCP-induced pancreatitis // Am. J. Gastroenterol.—2001.— Vol. 96 (7).— P.2098-2102.

103. Dunn J. A., Li С, На Т., Kao R. L., Browder W. Therapeutic modification of nuclear fac­ tor kappa В binding activity and tumor necrosis factor-alpha gene expression during acute biliary pancreatitis // Am. Surg.— 1997.—Vol.63.— P. 1036—1043.

104. Dutta S., Hubbard V., Appier M. Critical evaluation of the therapeutic efficacy of a pH sen­ sitive enteric-coated pancreatic enzyme preparation in the treatment of exocrine pancreatic